Clinical Trial Update: Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated pioglitazone for attenuating metabolic dysmetabolism in peritoneal dialysis patients, including effects on insulin resistan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Inflammation
• Insulin Resistance

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Huashan Hospital | Conditions: Peritoneal Dialysis, Pioglitazone | NA | Status: COMPLETED